Found: 70
Select item for more details and to access through your institution.
Systematic vitamin D supplementation is associated with improved outcomes and reduced thyroid adverse events in patients with cancer treated with immune checkpoint inhibitors: results from the prospective PROVIDENCE study.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 11, p. 3707, doi. 10.1007/s00262-023-03522-3
- By:
- Publication type:
- Article
The role of blood cholesterol quality in patients with advanced cancer receiving immune checkpoint inhibitors.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2127, doi. 10.1007/s00262-023-03398-3
- By:
- Publication type:
- Article
Immunotherapy-related adverse events in real-world patients with advanced non-small cell lung cancer on chemoimmunotherapy: a Spinnaker study sub-analysis.
- Published in:
- Frontiers in Oncology, 2023, p. 01, doi. 10.3389/fonc.2023.1163768
- By:
- Publication type:
- Article
Safe Administration of anti-PD-L1 Atezolizumab in a Patient with Metastatic Urothelial Cell Carcinoma and End-Stage Renal Disease on Dialysis.
- Published in:
- Case Reports in Oncological Medicine, 2019, p. 1, doi. 10.1155/2019/3452762
- By:
- Publication type:
- Article
Safe Administration of Ipilimumab, Pembrolizumab, and Nivolumab in a Patient with Metastatic Melanoma, Psoriasis, and a Previous Guillain–Barré Syndrome.
- Published in:
- Case Reports in Oncological Medicine, 2018, p. 1, doi. 10.1155/2018/2783917
- By:
- Publication type:
- Article
"Palliative" or "Supportive": Is It Just a Matter of Word?
- Published in:
- Journal of Palliative Medicine, 2018, v. 21, n. 11, p. 1546, doi. 10.1089/jpm.2018.0290
- By:
- Publication type:
- Article
Characterization of Age-Associated, Neutrophil-to-Lymphocyte Ratio (NLR) and Systemic Immune-Inflammatory Index (SII) as Biomarkers of Inflammation in Geriatric Patients with Cancer Treated with Immune Checkpoint Inhibitors: Impact on Efficacy and Survival
- Published in:
- Cancers, 2023, v. 15, n. 20, p. 5052, doi. 10.3390/cancers15205052
- By:
- Publication type:
- Article
Evaluation of Prognostic Factors for Survival in Transverse Colon Cancer.
- Published in:
- Cancers, 2020, v. 12, n. 9, p. 2457, doi. 10.3390/cancers12092457
- By:
- Publication type:
- Article
Evaluation of Second-Line Anti-VEGF after First-Line Anti-EGFR Based Therapy in RAS Wild-Type Metastatic Colorectal Cancer: The Multicenter "SLAVE" Study.
- Published in:
- Cancers, 2020, v. 12, n. 5, p. 1259, doi. 10.3390/cancers12051259
- By:
- Publication type:
- Article
Prognostic Impact of Blood Lipid Profile in Patients With Advanced Solid Tumors Treated With Immune Checkpoint Inhibitors: A Multicenter Cohort Study.
- Published in:
- Oncologist, 2024, v. 29, n. 3, p. e372, doi. 10.1093/oncolo/oyad273
- By:
- Publication type:
- Article
Clinical Outcomes of Patients with Advanced Cancer and Pre‐Existing Autoimmune Diseases Treated with Anti‐Programmed Death‐1 Immunotherapy: A Real‐World Transverse Study.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. e327, doi. 10.1634/theoncologist.2018-0618
- By:
- Publication type:
- Article
Association of Survival With Immune-Related Adverse Events—Time to Consider the Duration of Treatment.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Intra-patient Heterogeneity of BRAF and NRAS Molecular Alterations in Primary Melanoma and Metastases.
- Published in:
- Acta Dermato-Venereologica, 2020, v. 100, n. 1, p. 1, doi. 10.2340/00015555-3382
- By:
- Publication type:
- Article
Clinical Outcomes of Patients With Metastatic Urothelial Carcinoma After Progression to Immune Checkpoint Inhibitors: A Retrospective Analysis by the Meet-Uro Group (Meet-URO 1 Study).
- Published in:
- Clinical Medicine Insights: Oncology, 2021, p. 1, doi. 10.1177/11795549211021667
- By:
- Publication type:
- Article
Clinical Outcomes of Patients With Metastatic Urothelial Carcinoma After Progression to Immune Checkpoint Inhibitors: A Retrospective Analysis by the Meet-Uro Group (Meet-URO 1 Study).
- Published in:
- Clinical Medicine Insights: Oncology, 2021, v. 15, p. 1, doi. 10.1177/11795549211021667
- By:
- Publication type:
- Article
Immunotherapy in Hepatocellular Carcinoma.
- Published in:
- 2021
- By:
- Publication type:
- journal article
New Frontiers in the Medical Therapy of Hepatocellular Carcinoma.
- Published in:
- Chemotherapy (0009-3157), 2022, v. 67, n. 3, p. 164, doi. 10.1159/000521837
- By:
- Publication type:
- Article
Immune-related Adverse Events of Pembrolizumab in a Large Real-world Cohort of Patients With NSCLC With a PD-L1 Expression ≥ 50% and Their Relationship With Clinical Outcomes.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Weekly alternate intensive regimen FIrB/FOx in metastatic colorectal cancer patients: an update from clinical practice.
- Published in:
- OncoTargets & Therapy, 2019, v. 12, p. 2159, doi. 10.2147/OTT.S194745
- By:
- Publication type:
- Article
Are anti-PD1 and anti-PD-L1 alike? The non-small-cell lung cancer paradigm.
- Published in:
- Oncology Reviews, 2020, v. 14, n. 2, p. 135, doi. 10.4081/oncol.2020.490
- By:
- Publication type:
- Article
What cancer patients actually know regarding medical cannabis? A cross-sectional survey with a critical analysis of the current attitudes.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 6, p. 1439, doi. 10.1177/1078155219843161
- By:
- Publication type:
- Article
Author Correction: Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-49250-6
- By:
- Publication type:
- Article
Smoking status during first‐line immunotherapy and chemotherapy in NSCLC patients: A case–control matched analysis from a large multicenter study.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 6, p. 880, doi. 10.1111/1759-7714.13852
- By:
- Publication type:
- Article
Predictive value of skeletal muscle mass for immunotherapy with nivolumab in non‐small cell lung cancer patients: A "hypothesis‐generator" preliminary report.
- Published in:
- Thoracic Cancer, 2019, v. 10, n. 2, p. 347, doi. 10.1111/1759-7714.12965
- By:
- Publication type:
- Article
Family history of cancer and DNA damage response genes: Two sides of the same coin?
- Published in:
- Thoracic Cancer, 2019, v. 10, n. 2, p. 401, doi. 10.1111/1759-7714.12926
- By:
- Publication type:
- Article
Single‐institution study of correlations between skeletal muscle mass, its density, and clinical outcomes in non‐small cell lung cancer patients treated with first‐line chemotherapy.
- Published in:
- Thoracic Cancer, 2018, v. 9, n. 12, p. 1623, doi. 10.1111/1759-7714.12870
- By:
- Publication type:
- Article
Multicentric retrospective analysis of platinum‐pemetrexed regimens as first‐line therapy in non‐squamous non‐small cell lung cancer patients: A “snapshot” from clinical practice.
- Published in:
- Thoracic Cancer, 2018, v. 9, n. 2, p. 241, doi. 10.1111/1759-7714.12570
- By:
- Publication type:
- Article
COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211053416
- By:
- Publication type:
- Article
COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211053416
- By:
- Publication type:
- Article
Natural immunity to SARS-CoV-2 and breakthrough infections in vaccinated and unvaccinated patients with cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: an insight from clinical practice.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Knowledge and attitudes of Italian medical oncologists and palliative care physicians toward medical use of cannabis in cancer care: a national survey.
- Published in:
- Supportive Care in Cancer, 2021, v. 29, n. 12, p. 7845, doi. 10.1007/s00520-021-06383-7
- By:
- Publication type:
- Article
Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50%.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 11, p. 2209, doi. 10.1007/s00262-020-02613-9
- By:
- Publication type:
- Article
The Agnostic Role of Site of Metastasis in Predicting Outcomes in Cancer Patients Treated with Immunotherapy.
- Published in:
- Vaccines, 2020, v. 8, n. 2, p. 203, doi. 10.3390/vaccines8020203
- By:
- Publication type:
- Article
The Impact of Locoregional Treatment on Response to Nivolumab in Advanced Platinum Refractory Head and Neck Cancer: The Need Trial.
- Published in:
- Vaccines, 2020, v. 8, n. 2, p. 191, doi. 10.3390/vaccines8020191
- By:
- Publication type:
- Article
The possible different roles of denosumab in prevention and cure breast cancer bone metastases: A 'hypothesis-generator' study from clinical practice.
- Published in:
- Oncology Letters, 2018, v. 16, n. 6, p. 7195, doi. 10.3892/ol.2018.9561
- By:
- Publication type:
- Article
Notch pathway in small-cell lung cancer: from preclinical evidence to therapeutic challenges.
- Published in:
- Cellular Oncology (2211-3428), 2019, v. 42, n. 3, p. 261, doi. 10.1007/s13402-019-00441-3
- By:
- Publication type:
- Article
High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status.
- Published in:
- Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01226-2
- By:
- Publication type:
- Article
Immunotherapy for Metastatic Non-Small Cell Lung Cancer: Therapeutic Advances and Biomarkers.
- Published in:
- Current Oncology, 2023, v. 30, n. 2, p. 2366, doi. 10.3390/curroncol30020181
- By:
- Publication type:
- Article
Timed-flat infusion of 5-fluorouracil with docetaxel and oxaliplatin as first-line treatment of gastroesophageal adenocarcinoma: A single institution experience with the FD/FOx regimen.
- Published in:
- Oncology Reports, 2018, v. 40, n. 2, p. 803, doi. 10.3892/or.2018.6475
- By:
- Publication type:
- Article
Differential prognostic effect of systemic inflammation in patients with non–small cell lung cancer treated with immunotherapy or chemotherapy: A post hoc analysis of the phase 3 OAK trial.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 16, p. 3067, doi. 10.1002/cncr.34348
- By:
- Publication type:
- Article
Clinical implications of the family history in patients with lung cancer: a systematic review of the literature and a new cross-sectional/prospective study design (FAHIC: lung).
- Published in:
- Journal of Translational Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12967-024-05538-4
- By:
- Publication type:
- Article
Looking for A Place for Dose-Dense TMZ Regimens in GBM Patients: An Experience with MGMT Exploratory Evaluation.
- Published in:
- Bioengineering (Basel), 2019, v. 6, n. 1, p. 1, doi. 10.3390/bioengineering6010011
- By:
- Publication type:
- Article
The Gustave Roussy Immune (GRIm)-Score Variation Is an Early-on-Treatment Biomarker of Outcome in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Pembrolizumab.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 5, p. 1005, doi. 10.3390/jcm10051005
- By:
- Publication type:
- Article
The dynamics of circulating tumour DNA (ctDNA) during treatment reflects tumour response in advanced melanoma patients.
- Published in:
- Experimental Dermatology, 2023, v. 32, n. 10, p. 1785, doi. 10.1111/exd.14901
- By:
- Publication type:
- Article
GU-CA-COVID: a clinical audit among Italian genitourinary oncologists during the first COVID-19 outbreak.
- Published in:
- Therapeutic Advances in Urology, 2021, v. 13, p. 1, doi. 10.1177/17562872211054302
- By:
- Publication type:
- Article
The PERSONS score: A new tool for cancer patients' symptom assessment in simultaneous care and home care settings.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The PERSONS score for symptoms assessment in simultaneous care setting: A pilot study.
- Published in:
- 2019
- By:
- Publication type:
- journal article